ACLARION, INC. (ACON) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Win; EPS growth Lose.
16/44
1.8 / 5 stars
All 44 Win/Lose results and 76 gray no-data contests shown below
Every strict quarterly win earns 1 point. A loss or tie earns 0. A contest with no data is a gray cell, neither a win nor a loss, and leaves the total: stars are 5 × points won ÷ contests with data.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseACON / S&P -11.93% / 15.20% |
WinACON / S&P 33.07% / 15.00% |
LoseACON / S&P -99.75% / 50.40% |
| 2026-Q11/3 |
LoseACON / S&P -28.91% / -4.33% |
WinACON / S&P 42.63% / 11.30% |
LoseACON / S&P -99.79% / 27.70% |
| 2025-Q41/3 |
LoseACON / S&P -38.67% / 2.65% |
WinACON / S&P 65.63% / 9.00% |
LoseACON / S&P -99.79% / 13.40% |
| 2025-Q31/3 |
LoseACON / S&P -0.33% / 8.12% |
WinACON / S&P 36.91% / 4.61% |
LoseACON / S&P -98.15% / 13.45% |
| 2025-Q21/3 |
LoseACON / S&P -30.32% / 10.94% |
WinACON / S&P 16.69% / 4.83% |
LoseACON / S&P -96.57% / 10.63% |
| 2025-Q10/3 |
LoseACON / S&P -99.17% / -4.27% |
LoseACON / S&P -9.07% / 4.98% |
LoseACON / S&P -94.89% / 10.57% |
| 2024-Q40/3 |
LoseACON / S&P -21.31% / 2.41% |
LoseACON / S&P -39.36% / 5.25% |
LoseACON / S&P -89.65% / 6.15% |
| 2024-Q31/3 |
LoseACON / S&P -36.01% / 5.89% |
LoseACON / S&P -41.41% / 5.89% |
WinACON / S&P 338499.57% / 6.11% |
| 2024-Q21/3 |
LoseACON / S&P -13.33% / 4.28% |
LoseACON / S&P -35.23% / 5.38% |
WinACON / S&P 356668.02% / 5.12% |
| 2024-Q11/3 |
LoseACON / S&P -89.69% / 10.56% |
LoseACON / S&P -21.90% / 5.71% |
WinACON / S&P 389503.95% / 5.59% |
| 2023-Q42/3 |
LoseACON / S&P -38.65% / 11.69% |
WinACON / S&P 24.75% / 6.81% |
WinACON / S&P 389841.45% / 7.78% |
| 2023-Q32/3 |
LoseACON / S&P -52.75% / -3.27% |
WinACON / S&P 68.59% / 7.52% |
WinACON / S&P 637.86% / -5.03% |
| 2023-Q22/3 |
LoseACON / S&P 6.15% / 8.74% |
WinACON / S&P 95.76% / 9.50% |
WinACON / S&P 248.83% / -8.57% |
| 2023-Q12/2 |
WinACON / S&P 12.07% / 7.50% |
WinACON / S&P 33.75% / 10.77% |
No dataACON / S&P / -15.69% |
| 2022-Q40/2 |
LoseACON / S&P -25.45% / 7.56% |
LoseACON / S&P 0.25% / 11.88% |
No dataACON / S&P / -17.99% |
| 2022-Q30/1 |
LoseACON / S&P -14.88% / -4.88% |
No dataACON / S&P / 13.47% |
No dataACON / S&P / -1.41% |
| 2022-Q20/0 |
No dataACON / S&P / -16.10% |
No dataACON / S&P / 13.71% |
No dataACON / S&P / 11.04% |
| 2022-Q10/0 |
No dataACON / S&P / -4.60% |
No dataACON / S&P / 15.97% |
No dataACON / S&P / 42.23% |
| 2021-Q40/0 |
No dataACON / S&P / 11.03% |
No dataACON / S&P / 15.00% |
No dataACON / S&P / 96.40% |
| 2021-Q30/0 |
No dataACON / S&P / 0.58% |
No dataACON / S&P / 10.77% |
No dataACON / S&P / 69.42% |
| 2021-Q20/0 |
No dataACON / S&P / 8.55% |
No dataACON / S&P / 6.58% |
No dataACON / S&P / 51.81% |
| 2021-Q10/0 |
No dataACON / S&P / 6.17% |
No dataACON / S&P / -1.06% |
No dataACON / S&P / 7.39% |
| 2020-Q40/0 |
No dataACON / S&P / 12.15% |
No dataACON / S&P / -3.72% |
No dataACON / S&P / -33.42% |
| 2020-Q30/0 |
No dataACON / S&P / 8.93% |
No dataACON / S&P / -2.04% |
No dataACON / S&P / -27.10% |
| 2020-Q20/0 |
No dataACON / S&P / 20.54% |
No dataACON / S&P / -0.46% |
No dataACON / S&P / -27.11% |
| 2020-Q10/0 |
No dataACON / S&P / -19.60% |
No dataACON / S&P / 3.47% |
No dataACON / S&P / -14.75% |
| 2019-Q40/0 |
No dataACON / S&P / 9.07% |
No dataACON / S&P / 5.36% |
No dataACON / S&P / 2.99% |
| 2019-Q30/0 |
No dataACON / S&P / 1.70% |
No dataACON / S&P / 5.02% |
No dataACON / S&P / 0.21% |
| 2019-Q20/0 |
No dataACON / S&P / 4.30% |
No dataACON / S&P / 6.64% |
No dataACON / S&P / 8.65% |
| 2019-Q10/0 |
No dataACON / S&P / 13.65% |
No dataACON / S&P / 8.12% |
No dataACON / S&P / 14.29% |
| 2018-Q40/0 |
No dataACON / S&P / -13.52% |
No dataACON / S&P / 9.05% |
No dataACON / S&P / 18.23% |
| 2018-Q30/0 |
No dataACON / S&P / 7.71% |
No dataACON / S&P / 10.21% |
No dataACON / S&P / 19.06% |
| 2018-Q20/0 |
No dataACON / S&P / 3.43% |
No dataACON / S&P / 9.03% |
No dataACON / S&P / 14.46% |
| 2018-Q10/0 |
No dataACON / S&P / -0.76% |
No dataACON / S&P / 7.68% |
No dataACON / S&P / 12.46% |
| 2017-Q40/0 |
No dataACON / S&P / 6.64% |
No dataACON / S&P / 7.03% |
No dataACON / S&P / 13.82% |
| 2017-Q30/0 |
No dataACON / S&P / 4.48% |
No dataACON / S&P / 5.68% |
No dataACON / S&P / 17.57% |
| 2017-Q20/0 |
No dataACON / S&P / 3.09% |
No dataACON / S&P / 4.83% |
No dataACON / S&P / 17.74% |
| 2017-Q10/0 |
No dataACON / S&P / 6.07% |
No dataACON / S&P / 3.67% |
No dataACON / S&P / 13.32% |
| 2016-Q40/0 |
No dataACON / S&P / 3.82% |
No dataACON / S&P / 2.09% |
No dataACON / S&P / 7.05% |
| 2016-Q30/0 |
No dataACON / S&P / 3.85% |
No dataACON / S&P / 0.20% |
No dataACON / S&P / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | ACON total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -64.84% | 20.78% |
| Annualized return | -64.84% | 20.78% |
5Y · 2022-04-22 to 2026-08-27
| Metric | ACON total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 83.14% |
| Annualized return | -90.85% | 12.86% |
10Y · 2022-04-22 to 2026-08-27
| Metric | ACON total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -100.00% | 319.30% |
| Annualized return | -69.76% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |